BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
170 hedge funds and large institutions have $3.23B invested in Blueprint Medicines in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 72 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+32
Holders Change %
+23.19%
% of All Funds
3.86%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.23%
New
44
Increased
72
Reduced
39
Closed
12
Calls
$18.9M
Puts
$5.63M
Net Calls
+$13.3M
Net Calls Change
+$12.4M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
SG Americas Securities
New York
| – | -$604K | -8,673 | Closed |
|
|
FAM
177
Fred Alger Management
New York
| – | -$557K | -8,000 | Closed |
|
|
AP
178
AHL Partners
London,
United Kingdom
| – | -$419K | -6,003 | Closed |
|
179
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$244K | -3,500 | Closed |
|
|
TI
180
Turner Investments
Berwyn,
Pennsylvania
| – | -$209K | -3,000 | Closed |
|
|
RFS
181
Rockefeller Financial Services
New York
| – | -$160K | -2,303 | Closed |
|
|
NIT
182
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$118K | -1,700 | Closed |
|